About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
https://www.weizmann-usa.org/news-media/in-the-news/expanding-the-limits-of-the-possible-1/
Nov 07, 2022...
A rock star, a Paralympic swimmer, and a Nobel Prize in Physics laureate were among the nine recipients of honorary Doctor of Philosophy degrees from the Weizmann Institute of Science on Monday, November 7, bestowed upon them in recognition of their extraordinary contributions to society.
"Each one of tonight’s honorees has expanded the limits of the possible, while inspiring others to fulfill their own boundless potential," Prof. Alon Chen, president of the Weizmann Institute, said at the conferment ceremony, hosted by news anchor Lucy Aharish on campus at the Michael Sela Auditorium. Part of the Institute’s 74th Annual General Meeting of the International Board, the ceremony and related events are taking place in person — and as usual — for the first time since the outbreak of the COVID-19 pandemic.
Jan 25, 2023...
Researchers have for years tried to discover what determines “resilience to stress,” a term describing the ability to adapt to difficult situations and to overcome adversity. Is it acquired through experience, or is there a tendency to easily recover from stress possibly ingrained in us from a very early age or even from birth?
A new study lead by Prof. Gil Levkowitz of the molecular cell biology and molecular neuroscience departments at the Weizmann Institute of Science in Rehovot has revealed an important piece of this puzzle. The study examined zebrafish – small, black-and-white-striped, transparent fish whose natural habitat spans rivers, ponds and rice paddies in Pakistan, Myanmar, Nepal and India.
https://www.weizmann-usa.org/news-media/news-releases/treating-a-heart-attack-before-it-happens/
Mar 08, 2023...
REHOVOT, ISRAEL—March 8, 2023— Imagine getting treatment for a perfectly healthy young heart that would allow it to recover from an otherwise devastating injury decades later.
If you think this prospect seems farfetched, you are not alone. Until recently, Prof. Eldad Tzahor, whose lab at the Weizmann Institute of Science studies heart tissue regeneration, had also considered it science fiction. After all, cardiovascular diseases, which are humanity’s leading cause of death, aren’t generally perceived as something one can prepare for through preventive treatment. But Tzahor and researchers in his lab have now activated a cellular mechanism in healthy mouse hearts that makes these mice resilient to future heart attacks – even when they occur months later.
Apr 03, 2023...
Jerusalem, April 3, 2023 — The Blavatnik Family Foundation, the Israel Academy of Sciences and Humanities, and the New York Academy of Sciences, announced today the Laureates of the 2023 Blavatnik Awards for Young Scientists in Israel. This year’s Laureates, who will each receive $100,000, are:
The Blavatnik Awards recognize outstanding, innovative scientists at the early stages of their careers for both their extraordinary achievements and their promise for future discoveries. The prizes are awarded to researchers aged 42 and younger for groundbreaking work in the disciplines of Life Sciences, Chemistry, and Physical Sciences & Engineering. The Blavatnik Awards in Israel sit alongside their international counterparts, the Blavatnik National Awards and Blavatnik Regional Awards in the United States, and the Blavatnik Awards in the United Kingdom.
Aug 07, 2023...
REHOVOT, ISRAEL — August 8, 2023—Nonsmokers who develop lung cancer can be treated effectively with new drugs, but their tumors refuse to surrender without a fight. The drugs stop working in the long term because the tumors acquire secondary mutations that allow them to evade the medications’ therapeutic effect.
In research published today in the journal Cell Reports Medicine, investigators from the Weizmann Institute of Science report findings that may lead to relapse-free treatment for a sizeable subgroup of lung cancer patients. In a study in mice, scientists identified a biomarker that may help physicians treat select lung cancer patients with a single antibody-based drug that is likely to bring about full remission, without cancer relapse.
Aug 08, 2023...
To protect itself against disease, the human body has immune cells that patrol like police officers, entering disease cells and destroying them. But some dangerous cells, including some solid tumors, operate in stealth and cannot be targeted by the body’s regular immune system.
Edity Therapeutics, an Israeli startup founded in 2019, reprograms a patient’s own immune cells, giving them the ability to hunt down and destroy these cancer cells. It’s like transforming regular beat cops into lethal supersleuths.
Aug 08, 2023... Israeli study finds biological treatment effective for lung cancer
©2023 American Committee for the Weizmann Institute of Science
